CH449641A - Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen - Google Patents

Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen

Info

Publication number
CH449641A
CH449641A CH1618967A CH1618967A CH449641A CH 449641 A CH449641 A CH 449641A CH 1618967 A CH1618967 A CH 1618967A CH 1618967 A CH1618967 A CH 1618967A CH 449641 A CH449641 A CH 449641A
Authority
CH
Switzerland
Prior art keywords
benzomorphans
preparation
new substituted
substituted
new
Prior art date
Application number
CH1618967A
Other languages
German (de)
English (en)
Inventor
B Block Fred
H Clarke Frank
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of CH449641A publication Critical patent/CH449641A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Discharge Lamp (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH1618967A 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen CH449641A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
CH449641A true CH449641A (de) 1968-01-15

Family

ID=23297612

Family Applications (7)

Application Number Title Priority Date Filing Date
CH1618967A CH449641A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618767A CH449639A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618867A CH449640A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619067A CH449642A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538464A CH446371A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619167A CH449643A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538364A CH448118A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen

Family Applications After (6)

Application Number Title Priority Date Filing Date
CH1618767A CH449639A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618867A CH449640A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619067A CH449642A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538464A CH446371A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619167A CH449643A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538364A CH448118A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen

Country Status (12)

Country Link
AT (4) AT253687B (pm)
BE (2) BE657406A (pm)
CH (7) CH449641A (pm)
DE (2) DE1445853A1 (pm)
DK (4) DK108497C (pm)
ES (4) ES307299A1 (pm)
FR (2) FR4345M (pm)
GB (2) GB1077711A (pm)
IL (2) IL22643A (pm)
NL (3) NL6414820A (pm)
NO (2) NO119273B (pm)
SE (2) SE305657B (pm)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
WO2008106128A2 (en) 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
WO2009017664A1 (en) 2007-07-26 2009-02-05 Vitae Pharmaceuticals, Inc. CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
AR069545A1 (es) 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
EP2245014B1 (en) * 2008-02-12 2011-11-02 Boehringer Ingelheim International GmbH Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
JP5730021B2 (ja) 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロアルキルラクタム誘導体
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
US8138178B2 (en) 2008-05-01 2012-03-20 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8242111B2 (en) 2008-05-01 2012-08-14 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5696037B2 (ja) 2008-05-01 2015-04-08 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
CL2009001151A1 (es) 2008-05-13 2010-08-13 Boehringer Ingelheim Int Compuestos derivados de acidos carbociclicos aliciclicos de benzomorfanos, procedimiento de preparacion, composicion farmaceutica, utiles para tratar enfermedades influenciadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa, como trastornos metabolicos.
EP2324017B1 (en) 2008-07-25 2014-12-31 Boehringer Ingelheim International GmbH INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
PE20110566A1 (es) 2008-07-25 2011-09-02 Boehringer Ingelheim Int Inhibidores ciclicos de 11beta-hidroxiesteroide deshidrogenasa 1
AR073920A1 (es) 2008-10-23 2010-12-09 Boehringer Ingelheim Int Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
JP5679997B2 (ja) 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2010139673A1 (en) 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
JP5749263B2 (ja) 2009-07-01 2015-07-15 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
TWI531571B (zh) 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
KR20130137628A (ko) 2010-11-02 2013-12-17 베링거 인겔하임 인터내셔날 게엠베하 대사 장애를 치료하기 위한 약제학적 병용물
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
EP2744783A1 (en) 2011-08-17 2014-06-25 Boehringer Ingelheim International GmbH Indenopyridine derivatives

Also Published As

Publication number Publication date
SE305657B (pm) 1968-11-04
CH449643A (de) 1968-01-15
BE657406A (pm) 1965-06-21
ES307301A1 (es) 1965-05-16
DE1445854A1 (de) 1968-12-05
FR4345M (pm) 1966-08-16
ES307300A1 (es) 1965-05-01
SE322779B (pm) 1970-04-20
IL22643A (en) 1968-07-25
DE1445853A1 (de) 1968-12-05
CH449642A (de) 1968-01-15
AT249277B (de) 1966-09-12
NL6414821A (pm) 1965-06-21
FR4346M (pm) 1966-08-16
DK108497C (da) 1967-12-27
BE657405A (pm) 1965-06-21
DK108496C (da) 1967-12-27
DK106552C (da) 1967-02-20
ES307299A1 (es) 1965-05-16
ES307302A1 (es) 1965-05-16
IL22642A (en) 1968-07-25
NL6414820A (pm) 1965-06-21
GB1092394A (en) 1967-11-22
AT249276B (de) 1966-09-12
NO119273B (pm) 1970-04-27
AT261126B (de) 1968-04-10
AT253687B (de) 1967-04-25
CH449640A (de) 1968-01-15
DK108495C (da) 1967-12-27
CH449639A (de) 1968-01-15
NO119274B (pm) 1970-04-27
GB1077711A (en) 1967-08-02
CH448118A (de) 1967-12-15
NL127995C (pm)
CH446371A (de) 1967-11-15

Similar Documents

Publication Publication Date Title
CH446371A (de) Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH469731A (de) Verfahren zur Herstellung von neuen 1,2,4-Oxadiazolen
CH427833A (de) Verfahren zur Herstellung von neuen 1,3,5-Triazinen
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH430722A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-dibenz(b,e)-azepinen
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
AT244334B (de) Verfahren zur Herstellung von neuen 2, 1-Benzisothiazolen
AT251764B (de) Verfahren zur Herstellung von neuen 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
AT250372B (de) Verfahren zur Herstellung von neuen 4-Amino-5-hydroxypyridazonen-(6)
AT277984B (de) Verfahren zur Herstellung von neuen 4,4-Diphenylcyclohexylaminen
AT245566B (de) Verfahren zur Herstellung von neuen 1,2-Diaryl-4-alkyl-3,5-dioxo-pyrazolidinen
AT254169B (de) Verfahren zur Herstellung von neuen 1-Arylperchlor-2-azaalkenen-(2)
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH450450A (de) Verfahren zur Herstellung von neuen 1,4-Benzodioxanderivaten
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
AT248445B (de) Verfahren zur Herstellung von neuen 1, 2-Dimehtylhexahydropyridazinen
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH464174A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid
CH438316A (de) Verfahren zur Herstellung von substituierten 1,4-Benzoxazin-2-onen
AT246737B (de) Verfahren zur Herstellung von neuen 1,4-Benzodioxanderivaten
AT258292B (de) Verfahren zur Herstellung von 3,4-Dimethyl-8-nitrochinolin